Details of the Drug

General Information of Drug (ID: DMXTZYM)

Drug Name
SPK-RPE65
Indication
Disease Entry ICD 11 Status REF
Retinitis pigmentosa 9B70 Phase 3 [1]
Cross-matching ID
TTD ID
D0O7GB

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)